CSTL icon

Castle Biosciences
CSTL

Overview Fund Activity

160 hedge funds and large institutions have $988M invested in Castle Biosciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 72 increasing their positions, 42 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.53%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
23
Increased
72
Reduced
42
Closed
20
Calls
$480K
Puts
$8K
Net Calls
+$472K
Net Calls Change
+$381K

Top Buyers

1
BG
1
Bellevue Group
Switzerland
$27.3M
2
WA
2
Wasatch Advisors
Utah
$154M
3
NCGI
3
Next Century Growth Investors
Minnesota
$24.2M
4
IECM
4
Intrinsic Edge Capital Management
Illinois
$9.53M
5
GPGA
5
Grandeur Peak Global Advisors
Utah
$24.4M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$12.2M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.12M
4
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$19.2M
5
RI
5
RTW Investments
New York
$22.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
176
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$5K -108 Closed
DFCM
177
Dark Forest Capital Management
Puerto Rico
– -$4K -87 Closed
4 5 6 7
8